StockData
Healthpeak Properties, Inc. logo

Healthpeak Properties, Inc. (DOC) stock analysis

DOCNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3021% above fair value
$20.38−0.03 (-0.15%)

Close on Nov 11, 2026Market cap $14.05BP/E 58.2Yield 5.99%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth4Performance0Health0Dividend3

Weak8 of 30 checks passed

Healthpeak Properties passes 8 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
4/6
Past performance
0/6
Financial health
0/6
Dividend
3/6

What stands out

  • Revenue growing 10%+ a year

    Revenue grew 11.0% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 47.5% over the last twelve months, against a 5-year average of -29.6% a year.

  • Guidance raised

    Healthpeak Properties raised its Full Year 2026 Total Same-Store Cash (Adjusted) NOI outlook on Aug 4, 2026.

  • EV/EBITDA below its 5-year median

    Healthpeak Properties's EV/EBITDA of 7.5 is below its 5-year median of 8.7.

What to watch

  • Margin of safety under 20%

    The price is 20.9% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $20.38 is above our fair value estimate of $16.85.

  • Return on equity under 15%

    Return on equity was 3.1% over the last twelve months and averaged 4.8% over five years; we look for 15% on both.

  • Earnings shrank over 5 years

    Net income shrank 29.6% a year on average over the last five fiscal years.

Valuation1/6
  • P/E above its 5-year median

    Healthpeak Properties's P/E of 58.2 is above its own 5-year median of 43.7.

  • P/E above the industry

    Healthpeak Properties's P/E of 58.2 is above the Miscellaneous Investing median of 26.3.

  • EV/EBITDA below its 5-year median

    Healthpeak Properties's EV/EBITDA of 7.5 is below its 5-year median of 8.7.

  • P/B above the industry

    Healthpeak Properties's price-to-book of 1.79 is above the Miscellaneous Investing median of 1.20.

  • Trading above fair value

    The share price of $20.38 is above our fair value estimate of $16.85.

  • Margin of safety under 20%

    The price is 20.9% above fair value, so there is no margin of safety.

Growth4/6
  • Revenue growing 10%+ a year

    Revenue grew 11.0% a year over the last three fiscal years.

  • EPS growing under 10% a year

    Diluted EPS grew -52.3% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 47.5% over the last twelve months, against a 5-year average of -29.6% a year.

  • Growing faster than the industry

    Revenue grew 5.5% over the last twelve months; the Miscellaneous Investing median is 4.6%.

  • Guidance raised

    Healthpeak Properties raised its Full Year 2026 Total Same-Store Cash (Adjusted) NOI outlook on Aug 4, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance0/6
  • Return on equity under 15%

    Return on equity was 3.1% over the last twelve months and averaged 4.8% over five years; we look for 15% on both.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity below the industry

    Healthpeak Properties's return on equity of 3.1% is below the Miscellaneous Investing median of 3.1%.

  • Earnings shrank over 5 years

    Net income shrank 29.6% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 8.2% over the last twelve months, against a 5-year average of 15.3%.

  • Net margin below the industry

    Healthpeak Properties's net margin of 8.2% is below the Miscellaneous Investing median of 10.3%.

Financial health0/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt coverage

    Needs operating cash flow.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.83; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Healthpeak Properties paid dividends worth 6.0% of the share price over the last twelve months.

  • Yield above Treasuries

    The 6.0% yield is above the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Healthpeak Properties yields 6.0%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Not covered by earnings

    Dividends take 348% of net income, leaving little room.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$16.85

The share price is 21% above this estimate.

20%+ below
Near fair value
20%+ above
$20.38Price$16.85Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E35.1×43.7×26.3×$12.2940%
EV/EBITDA9.1×8.7×9.5×$27.1735%
P/B1.5×1.7×1.2×$16.5410%
Earnings power8.4% cost of equity––$5.1515%
Fair value$16.85100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 43.7
  • Miscellaneous Investing median 26.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$120.49M
Value traded per 1% price move
$94.01M

Downside

Low risk

Typical loss in a bad month
10.8%
Volatility (annualized)
29%
Sharpe ratio, 1 year
0.37
Beta to the S&P 500 (5Y)
0.71

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

–

Net margin

2.5%−22.6 pts over 5 years

See a number that looks wrong?